J. Mendoza

L. Goodglick, P. Pantazis, J. Wyche, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Desmoplastic small round cell tumor (DSRCT) xenografts and tissue culture lines: Establishment and initial characterization

B. Giovanella, J. Mendoza, D. Vardeman, 2013, Oncology letters.

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.

R. Bast, C. Verschraegen, A. Kudelka, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The role of pH and serum albumin in the metabolic conversion of 9‐nitrocamptothecin to 9‐aminocamptothecin by human hematopoietic and other cells

P. Pantazis, B. Giovanella, J. Mendoza, 1995, European journal of haematology.

Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.

P. Pantazis, B. Giovanella, J. Mendoza, 1995, Leukemia research.

Conversion of 9‐nitro‐camptothecin to 9‐amino‐camptothecin by human blood cells in vitro

P. Pantazis, B. Giovanella, J. Mendoza, 1994, European journal of haematology.

Partial characterization of human leukemia U‐937 cell sublines resistant to 9‐nitrocamptothecin P

D. Kufe, P. Pantazis, B. Giovanella, 1994, European journal of haematology.

Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells in vitro

P. Pantazis, B. Giovanella, J. Mendoza, 1993, International journal of cancer.

9‐nitro‐camptothecin delays growth of U‐937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro

P. Pantazis, B. Giovanella, J. Mendoza, 1993, European journal of haematology.

Pharmacology of Camptothecin Esters

B. Giovanella, J. Liehr, J. Mendoza, 2000, Annals of the New York Academy of Sciences.

in Vitro Human Breast Cells Differential Response of Nontumorigenic and Tumorigenic Immunodeficient Mice Treated with 9-Nitrocamptothecin : Regression of Human Breast Carcinoma Tumors in Updated

Pantazis, Anthony, Panayotis, 2006 .

Anticancer activity of new haloalkyl camptothecin esters against human cancer cell lines and human tumor xenografts grown in nude mice.

C. Zhan, B. Giovanella, J. Mendoza, 2012, Anti-Cancer Agents in Medicinal Chemistry.

Synthesis and antitumor activity of aromatic camptothecin esters.

B. Giovanella, J. Mendoza, A. Dejesus, 2008, International journal of molecular medicine.

Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers 1

R. Bast, C. Verschraegen, A. Kudelka, 2003 .

Development of resistance to 9‐nitro‐camptothecin by human leukemia U‐937 cells in vitro correlates with altered sensitivities to several anticancer drugs

J. Mendoza, A. Dejesus, J. Early, 1994, Anti-cancer drugs.

Growth Inhibition of Human Cancer Metastases by Camptothecins in Newly Developed Xenograft Models 1

B. Giovanella, M. Potměšil, J. Stehlin, 2006 .

Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.

B. Giovanella, J. Stehlin, J. Mendoza, 1984, Journal of the National Cancer Institute.

Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.

B. Aggarwal, P. Pantazis, U. Raju, 1998, Anti-cancer drugs.

Studies of time/dose intensity in treatment of human cancer xenografts with camptothecin analogues

B. Giovanella, M. Potměšil, J. Stehlin, 1994 .